Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 261–261 | Cite as

Vedolizumab

Various toxicities: 13 case reports
Case report
  • 19 Downloads

Reference

  1. Kopylov U, et al. Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience. Digestive and Liver Disease 51: 68-74, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.dld.2018.07.040 - Israel

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations